PTGX vs MSFT: Which Stock is Better?
Side-by-side comparison of Protagonist Therapeutics Inc and Microsoft Corporation in 2026
PTGX
Protagonist Therapeutics Inc
$146.50
MSFT
Microsoft Corporation
$499.32
Key Metrics Comparison
| Metric | PTGX | MSFT | Winner |
|---|---|---|---|
| Market Cap | $7.25B | $3.71T | MSFT |
| P/E Ratio | 121.59 | 33.89 | MSFT |
| EPS (TTM) | $0.66 | $14.08 | MSFT |
| Revenue Growth | 0.8% | 18.4% | MSFT |
| Gross Margin | 0.0% | 67.9% | MSFT |
Analyze PTGX
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PTGX or MSFT a better investment?
Comparing PTGX and MSFT: Protagonist Therapeutics Inc has a market cap of $7.25B while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PTGX and MSFT?
PTGX (Protagonist Therapeutics Inc) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PTGX or MSFT?
Based on P/E ratios, MSFT trades at a lower multiple (33.9x vs 121.6x).
Which is growing faster: PTGX or MSFT?
MSFT has higher revenue growth at 18.4% vs 0.8% for PTGX.
Which company is more profitable: PTGX or MSFT?
Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for PTGX.
Which is the larger company: PTGX or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $7.25B for PTGX.
Should I buy PTGX or MSFT in 2026?
Both PTGX and MSFT have investment merit. PTGX trades at $146.50 while MSFT trades at $499.32. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PTGX and MSFT stock?
Key differences: Market Cap ($7.25B vs $3.71T), P/E Ratio (121.6x vs 33.9x), Revenue Growth (0.8% vs 18.4%), Gross Margin (0.0% vs 67.9%).
Should I buy PTGX or MSFT in 2026?
The choice between PTGX and MSFT depends on your investment goals. MSFT shows higher revenue growth (18.4%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between PTGX and MSFT?
PTGX (Protagonist Therapeutics Inc) has a market cap of $7.25B, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.